{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:13:14Z","timestamp":1760202794625,"version":"3.44.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.cpcardiol.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T01:13:36Z","timestamp":1543540416000},"page":"100402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Medical and Endovascular Treatment of PAD: A Review of the Guidelines and Pivotal Clinical Trials"],"prefix":"10.1016","volume":"45","author":[{"given":"Rajan A.G.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Sakhuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8618-7539","authenticated-orcid":false,"given":"Christopher J.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0001","first-page":"e38","article-title":"Heart disease and stroke statistics-2016 update: a Report From the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0002","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0003","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jvs.2013.01.053","article-title":"Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories","volume":"58","author":"Berger","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0004","first-page":"e726","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0005","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0006","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.286.13.1599","article-title":"Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment","volume":"286","author":"McDermott","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0007","first-page":"499","article-title":"[Surgical treatment of peripheral circulation disorders]","volume":"21","author":"Fontaine","year":"1954","journal-title":"Helv Chir Acta"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0008","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0009","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1078-5884(97)80067-6","article-title":"Critical and subcritical ischaemia","volume":"13","author":"Wolfe","year":"1997","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0011","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0012","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0013","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","article-title":"Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial","volume":"49","author":"Bhatt","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000123.pub2","article-title":"Lipid-lowering for peripheral arterial disease of the lower limb","author":"Aung","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0016","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0017","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/HYPERTENSIONAHA.109.142240","article-title":"Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the international VErapamil-SR\/Trandolapril study","volume":"55","author":"Bavry","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0018","doi-asserted-by":"crossref","first-page":"147514","DOI":"10.1007\/s11606-014-2947-1","article-title":"Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT","volume":"29","author":"Piller","year":"2014","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0019","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.hjh.0000249692.96488.46","article-title":"Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial","volume":"24","author":"Zanchetti","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0020","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/HJH.0b013e3283471151","article-title":"Effect of nebivolol vs. hydrochlorothiazide on the walking capacity in hypertensive patients with intermittent claudication","volume":"29","author":"Diehm","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0021","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/HYPERTENSIONAHA.110.169169","article-title":"beta-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial","volume":"58","author":"Espinola-Klein","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005508.pub3","article-title":"Beta blockers for peripheral arterial disease","author":"Paravastu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0023","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ehj.2003.10.033","article-title":"Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease","volume":"25","author":"Ostergren","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0025","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0026","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40265-015-0364-3","article-title":"Clinical efficacy and safety of cilostazol: a critical review of the literature","volume":"75","author":"Rogers","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003748.pub4","article-title":"Cilostazol for intermittent claudication","author":"Bedenis","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0028","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1538574413518121","article-title":"Effect of cilostazol prescribed in a pragmatic treatment program for intermittent claudication","volume":"48","author":"Lee","year":"2014","journal-title":"Vasc Endovasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0029","doi-asserted-by":"crossref","first-page":"e63499","DOI":"10.1371\/journal.pone.0063499","article-title":"Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes","volume":"8","author":"Leeper","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0030","article-title":"Pentoxifylline for intermittent claudication","volume":"9","author":"Salhiyyah","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0031","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"A comparison of cilostazol and pentoxifylline for treating intermittent claudication","volume":"109","author":"Dawson","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0032","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jacc.2006.09.004","article-title":"Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association\/American College of Cardiology","volume":"48","author":"Davis","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0033","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ehj.2003.10.018","article-title":"Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study","volume":"25","author":"Gurfinkel","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0034","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/eurheartj\/ehm581","article-title":"Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study","volume":"29","author":"Ciszewski","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0036","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.CIR.81.2.602","article-title":"Benefit of exercise conditioning for patients with peripheral arterial disease","volume":"81","author":"Hiatt","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0037","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40279-014-0261-z","article-title":"Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis","volume":"45","author":"Parmenter","year":"2015","journal-title":"Sports Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0038","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1358863X14559092","article-title":"Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis","volume":"20","author":"Parmenter","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0039","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00508-014-0548-y","article-title":"Evaluation of 6- and 12-month supervised exercise training on strength and endurance parameters in patients with peripheral arterial disease","volume":"126","author":"Pilz","year":"2014","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0741-5214(05)80040-0","article-title":"Exercise training improves functional status in patients with peripheral arterial disease","volume":"23","author":"Regensteiner","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0041","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/1358863X9700200313","article-title":"Exercise in the treatment of claudication: assessment and treatment of functional impairment","volume":"2","author":"Regensteiner","year":"1997","journal-title":"Vasc Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0042","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMra021135","article-title":"Exercise training for claudication","volume":"347","author":"Stewart","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0043","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.apmr.2011.02.007","article-title":"Long-term effects of structured home-based exercise program on functional capacity and quality of life in patients with intermittent claudication","volume":"92","author":"Fakhry","year":"2011","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0044","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3810\/psm.2012.05.1964","article-title":"Exercise interventions for patients with peripheral arterial disease: a review of the literature","volume":"40","author":"Brenner","year":"2012","journal-title":"Physician Sportsmed"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0045","article-title":"Exercise for intermittent claudication","volume":"12","author":"Lane","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0046","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCULATIONAHA.111.075770","article-title":"Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study","volume":"125","author":"Murphy","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0047","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2014.12.043","article-title":"Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study","volume":"65","author":"Murphy","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0048","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.2015.14851","article-title":"Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial","volume":"314","author":"Fakhry","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0049","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.2337\/dc10-2399","article-title":"Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial","volume":"34","author":"Collins","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001107","article-title":"Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial","volume":"3","author":"Gardner","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0051","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cct.2012.08.001","article-title":"The Group Oriented Arterial Leg Study (GOALS) to improve walking performance in patients with peripheral arterial disease","volume":"33","author":"McDermott","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0052","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2013.7231","article-title":"Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial","volume":"310","author":"McDermott","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0053","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCULATIONAHA.110.963066","article-title":"Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial","volume":"123","author":"Gardner","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0054","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1358863X15572725","article-title":"Community-based walking exercise for peripheral artery disease: an exploratory pilot study","volume":"20","author":"Mays","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1358863X08101858","article-title":"Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication","volume":"14","author":"Treat-Jacobson","year":"2009","journal-title":"Vasc Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0056","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1067\/mva.2002.123756","article-title":"Increasing exercise tolerance of persons limited by claudication pain using polestriding","volume":"35","author":"Langbein","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0057","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1067\/mva.2000.104104","article-title":"Influence of upper- and lower-limb exercise training on cardiovascular function and walking distances in patients with intermittent claudication","volume":"31","author":"Walker","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0058","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejvs.2014.04.002","article-title":"Systematic review and meta-analysis of direct versus indirect angiosomal revascularisation of infrapopliteal arteries","volume":"48","author":"Bosanquet","year":"2014","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0059","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejvs.2013.12.010","article-title":"Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis","volume":"47","author":"Biancari","year":"2014","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0060","first-page":"611","volume":"86","author":"Jaff","year":"2015","journal-title":"Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0061","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jacc.2015.12.049","article-title":"Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options","volume":"67","author":"Olin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0062","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jvs.2010.04.080","article-title":"A systematic review of endovascular treatment of extensive aortoiliac occlusive disease","volume":"52","author":"Jongkind","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0063","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jvs.2005.09.034","article-title":"Endovascular management of iliac artery occlusions: extending treatment to transatlantic inter-society consensus class C and D patients","volume":"43","author":"Leville","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0064","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jvs.2008.07.004","article-title":"The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction","volume":"48","author":"Kashyap","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0065","first-page":"228","article-title":"Percutaneous endoluminal treatment of iliac occlusions: long-term follow-up in 105 patients","volume":"5","author":"Henry","year":"1998","journal-title":"J Cndovasc Surg Off J Int Soc Endovasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0066","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jvs.2005.05.002","article-title":"Long-term outcomes and predictors of iliac angioplasty with selective stenting","volume":"42","author":"Kudo","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0067","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0002-9343(01)00727-6","article-title":"Stent-supported recanalization of chronic iliac artery occlusions","volume":"110","author":"Scheinert","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0068","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.avsg.2014.12.027","article-title":"24-Month Data from the BRAVISSIMO: a large-scale prospective registry on iliac stenting for TASC A & B and TASC C & D lesions","volume":"29","author":"de Donato","year":"2015","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0069","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jvs.2011.06.097","article-title":"A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease","volume":"54","author":"Mwipatayi","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1745-6215-13-215","article-title":"DISCOVER: Dutch Iliac Stent trial: COVERed balloon-expandable versus uncovered balloon-expandable stents in the common iliac artery: study protocol for a randomized controlled trial","volume":"13","author":"Bekken","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0071","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jacc.2011.01.070","article-title":"Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures","volume":"58","author":"Bonvini","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0072","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1358863X11404280","article-title":"Catheter-based therapy of common femoral artery atherosclerotic disease","volume":"16","author":"Paris","year":"2011","journal-title":"Vasc Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0073","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jvs.2016.03.418","article-title":"Percutaneous common femoral artery interventions using angioplasty, atherectomy, and stenting","volume":"64","author":"Mehta","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0074","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jvir.2012.10.020","article-title":"Angioplasty and provisional stent treatment of common femoral artery lesions","volume":"24","author":"Bonvini","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0075","first-page":"1013","article-title":"Acute and medium-term outcomes of endovascular therapy of obstructive disease of diverse etiology of the common femoral artery","volume":"81","author":"Dattilo","year":"2013","journal-title":"Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0076","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jcin.2017.03.046","article-title":"Stenting or Surgery for De Novo Common Femoral Artery Stenosis","volume":"10","author":"Goueffic","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0077","article-title":"Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease","author":"Imran","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0078","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1526602817748319","article-title":"Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for common femoral artery atherosclerotic disease","volume":"25","author":"Stavroulakis","year":"2018","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0079","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0036-1572524","article-title":"Safety and Effectiveness of Closure Devices Applied to a Stented Common Femoral Artery: A Retrospective Analysis","volume":"25","author":"Shammas","year":"2016","journal-title":"Int J Angiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0080","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s11517-011-0815-2","article-title":"The consequences of the mechanical environment of peripheral arteries for nitinol stenting","volume":"49","author":"Early","year":"2011","journal-title":"Med Biol Eng Comput"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0081","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejvs.2008.05.005","article-title":"The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings","volume":"36","author":"Rits","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0082","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0083","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.107.689141","article-title":"Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)","volume":"116","author":"Krankenberg","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0084","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0085","first-page":"1090","article-title":"Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions","volume":"74","author":"Dick","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0086","first-page":"58","article-title":"Long-term outcomes of self-expandable nitinol stent implantation with intraluminal angioplasty to treat chronic total occlusion in the superficial femoral artery (transatlantic inter-society consensus type D lesions)","volume":"28","author":"Matsumi","year":"2016","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0087","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0088","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0089","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0090","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1526602815626557","article-title":"Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability","volume":"23","author":"Katsanos","year":"2016","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0091","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011245","article-title":"Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK","volume":"6","author":"Katsanos","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0092","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jvs.2017.05.098","article-title":"Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial","volume":"66","author":"Jongsma","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0093","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1583\/13-4630MR.1","article-title":"Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions","volume":"21","author":"Zeller","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0094","article-title":"SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions","author":"Feldman","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0095","first-page":"1047","article-title":"Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease","volume":"76","author":"Schmidt","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0096","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0097","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1016\/j.jvs.2010.01.073","article-title":"Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy","volume":"51","author":"Bradbury","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0098","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jcin.2014.06.018","article-title":"Two-year life expectancy in patients with critical limb ischemia","volume":"7","author":"Soga","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0099","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.tvir.2014.08.012","article-title":"The BEST-CLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia","volume":"17","author":"Farber","year":"2014","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0100","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.jcin.2016.09.039","article-title":"Endovascular Therapy versus bypass surgery as first-line treatment strategies for critical limb ischemia: results of the interim analysis of the CRITISCH registry","volume":"9","author":"Bisdas","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0101","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jcin.2015.07.005","volume":"8","author":"Iida","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0102","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","article-title":"Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia","volume":"128","author":"Liistro","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0103","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0104","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jcin.2015.07.011","volume":"8","author":"Zeller","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0105","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2012.08.989","article-title":"A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial","volume":"60","author":"Scheinert","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0106","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcin.2015.10.038","volume":"9","author":"Katsanos","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0107","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jvs.2011.07.099","article-title":"Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease","volume":"55","author":"Bosiers","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0108","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1093\/eurheartj\/ehr144","article-title":"Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial","volume":"32","author":"Rastan","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0109","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial","volume":"60","author":"Rastan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2018.09.004_bib0110","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2014.04.015","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial","volume":"7","author":"Siablis","year":"2014","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280618301415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280618301415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:56:29Z","timestamp":1758938189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280618301415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":110,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0146280618301415"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2018.09.004","relation":{},"ISSN":["0146-2806"],"issn-type":[{"type":"print","value":"0146-2806"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Medical and Endovascular Treatment of PAD: A Review of the Guidelines and Pivotal Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100402"}}